Columbia, SCNCT07518407Now EnrollingIRB Ready

Obesity Type 2 Diabetes Mellitus Clinical Trial in Columbia, SC

Access cutting-edge obesity type 2 diabetes mellitus treatment through this clinical trial at a research site in Columbia. Study-provided care at no cost to qualified participants.

Sponsored by University of South Carolina

Quick Self-Assessment

See if you qualify for this Columbia location

Preparing your pre-screening questions…

Expert Care in Columbia

Access obesity type 2 diabetes mellitus specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related obesity type 2 diabetes mellitus treatment provided free

Apply for This Columbia Location

Check if you qualify for this obesity type 2 diabetes mellitus clinical trial in Columbia, SC

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Columbia

    Convenient for SC residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Columbia site if eligible
  4. 4Begin participation

About This Obesity Type 2 Diabetes Mellitus Study in Columbia

This pilot study will evaluate the feasibility, acceptability, and perceived usefulness of the SWITCH mobile nutrition behavioral intervention among adults receiving GLP-1 receptor agonist therapy for obesity and/or type 2 diabetes. Participants will complete baseline assessments, receive a 6-week app-based nutrition intervention consisting of daily dietary self-monitoring and weekly learning modules, and complete follow-up assessments and a structured interview.

Sponsor: University of South Carolina

Who Can Participate

Inclusion Criteria

• Age between 18 and 65 years.
BMI between 30 - 49.9 kg/m2 and/or diagnosed with type 2 diabetes.
Currently prescribed and using GLP-1 receptor therapy for at least 4 weeks.
Own a smartphone (Android or iOS) with an active data plan to support app-based intervention delivery.
Residing anywhere in the United States.
Must be willing and able to reduce caloric intake.
Be free of major health or psychiatric diseases, drug, or alcohol dependency.
Willing to sign informed consent.

Exclusion Criteria

• Presence of type 1 diabetes mellitus
Severe complications, including but not limited to proliferative retinopathy, severe peripheral neuropathy, nephropathy requiring dialysis, active foot ulcers, or recent hospitalization for diabetic ketoacidosis or hyperosmolar hyperglycemic state within the past 6 months.
Current or recent (within 6 months) participation in another structured weight loss program or clinical trial that may interfere with study outcomes.
Pregnancy, breastfeeding, or plans to become pregnant during the study period.
Current use of another investigational weight loss device or medication.
Diagnosed eating disorders (e.g., anorexia nervosa, bulimia nervosa, binge eating disorder) or other psychiatric conditions that may affect adherence to behavioral interventions, as determined by study staff.
Severe cardiovascular, hepatic, renal, or pulmonary disease that would limit participation in moderate physical activity or dietary modification.
Active cancer treatment (chemotherapy, radiation, or surgery) within the past 12 months.
Substance use disorder or alcohol dependency within the past 12 months.
Cognitive impairment or any medical or mental condition that would interfere with the ability to understand or comply with study procedures.
Lack of reliable internet or smartphone access, or unwillingness to use a mobile app for tracking and communication.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Columbia?

Yes, this clinical trial (NCT07518407) has an active research site in Columbia, SC that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Obesity Type 2 Diabetes Mellitus Treatment Options in Columbia, SC

If you're searching for obesity type 2 diabetes mellitus treatment options in Columbia, SC, this clinical trial (NCT07518407) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Columbia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced obesity type 2 diabetes mellitus specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all obesity type 2 diabetes mellitus clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Columbia, SC

See all pulmonary embolism clinical trials recruiting in Columbia — not just this study.

Browse Pulmonary Embolism Trials in Columbia

Ready to Join in Columbia?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Columbia, SC